Literature DB >> 26642101

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.

Alan J Garber, Martin Julian Abrahamson, Joshua I Barzilay, Lawrence Blonde, Zachary T Bloomgarden, Michael A Bush, Samuel Dagogo-Jack, Michael B Davidson, Daniel Einhorn, Jeffrey R Garber, W Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B Hirsch, Paul S Jellinger, Janet B McGill, Jeffrey I Mechanick, Paul David Rosenblit, Guillermo E Umpierrez.   

Abstract

This document represents the official position of the American Association of Clinical Endocrinologists and the American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26642101     DOI: 10.4158/EP151063.CS

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  10 in total

Review 1.  Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities.

Authors:  David Rodbard
Journal:  Diabetes Technol Ther       Date:  2016-02       Impact factor: 6.118

2.  Postprandial GLP-2 Levels Are Increased After Biliopancreatic Diversion in Diabetic Individuals with Class I Obesity: a Prospective Study.

Authors:  Everton Cazzo; José Carlos Pareja; Bruno Geloneze; Elinton Adami Chaim; Maria Rita Lazzarini Barreto; Daniéla Oliveira Magro
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

3.  Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome.

Authors:  Roberto Mioni; Anna Dalla Cà; Jenni Turra; Sara Azzolini; Nadia Xamin; Luigi Bleve; Pietro Maffei; Roberto Vettor; Francesco Fallo
Journal:  Endocrine       Date:  2016-05-03       Impact factor: 3.633

4.  Insulin secretion is a strong predictor for need of insulin therapy in patients with new-onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT study.

Authors:  Siham Abdelgani; Curtiss Puckett; John Adams; Curtis Triplitt; Ralph A DeFronzo; Muhammad Abdul-Ghani
Journal:  Diabetes Obes Metab       Date:  2021-05-06       Impact factor: 6.408

Review 5.  Lipedema: friend and foe.

Authors:  Yanira Sanchez-De la Torre; Rita Wadeea; Victoria Rosas; Karen L Herbst
Journal:  Horm Mol Biol Clin Investig       Date:  2018-03-09

6.  Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm.

Authors:  Muhammad Abdul-Ghani; Ralph A DeFronzo
Journal:  Diabetes Care       Date:  2017-08       Impact factor: 19.112

Review 7.  Glucagon-like peptide-1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Sonal Singh; Eugene E Wright; Anita Y M Kwan; Juliette C Thompson; Iqra A Syed; Ellen E Korol; Nathalie A Waser; Maria B Yu; Rattan Juneja
Journal:  Diabetes Obes Metab       Date:  2016-12-05       Impact factor: 6.577

8.  Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin.

Authors:  Jessica R Wilson; Megan M Shuey; Nancy J Brown; Jessica K Devin
Journal:  J Endocr Soc       Date:  2017-08-01

9.  Combining Bioinformatics Techniques to Study Diabetes Biomarkers and Related Molecular Mechanisms.

Authors:  Han Nie; Kaihua Zhang; Jiasheng Xu; Kaili Liao; Weimin Zhou; Zhonghua Fu
Journal:  Front Genet       Date:  2020-04-30       Impact factor: 4.599

10.  Obesity Pharmacotherapy in Patients With Type 2 Diabetes.

Authors:  Scott Kahan; Ken Fujioka
Journal:  Diabetes Spectr       Date:  2017-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.